Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:1355-1362

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasad, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasad, K.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress

(Circulation. 1999;99:1355-1362.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Reduction of Serum Cholesterol and Hypercholesterolemic Atherosclerosis in Rabbits by Secoisolariciresinol Diglucoside Isolated From Flaxseed

Kailash Prasad, MD, PhD, FRCPC

From the Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Background—Secoisolariciresinol diglucoside (SDG) is a plant lignan isolated from flaxseed. Lignans are platelet-activating factor–receptor antagonists that would inhibit the production of oxygen radicals by polymorphonuclear leukocytes. SDG is an antioxidant. Antioxidants studied thus far are known to reduce hypercholesterolemic atherosclerosis. The objective of this study was to determine the effect of SDG on various blood lipid and aortic tissue oxidative stress parameters and on the development of atherosclerosis in rabbits fed a high-cholesterol diet.

Methods and Results—Rabbits were assigned to 4 groups: group 1, control; group 2, SDG control (15 mg · kg body wt-1 · d-1 PO); group 3, 1% cholesterol diet; and group 4, same as group 3 but with added SDG (15 mg · kg body wt-1 · d-1 PO). Blood samples were collected before (time 0) and after 4 and 8 weeks of experimental diets for measurement of serum triglycerides, total cholesterol (TC), and LDL, HDL, and VLDL cholesterol (LDL-C, HDL-C, and VLDL-C). The aorta was removed at the end of the protocol for assessment of atherosclerotic plaques; malondialdehyde, an aortic tissue lipid peroxidation product; and aortic tissue chemiluminescence, a marker for antioxidant reserve. Serum TC, LDL-C, and the ratios LDL-C/HDL-C and TC/HDL-C increased in groups 3 and 4 compared with time 0, the increase being smaller in group 4 than in group 3. Serum HDL-C decreased in group 3 and increased in group 4 compared with time 0, but changes were lower in group 3 than in group 4. SDG reduced TC and LDL-C by 33% and 35%, respectively, at week 8 but increased HDL-C significantly, by>140%, as early as week 4. It also decreased TC/LDL-C and LDL-C/HDL-C ratios by {approx}64%. There was an increase in aortic malondialdehyde and chemiluminescence in group 3, and they were lower in group 4 than in group 3. SDG reduced hypercholesterolemic atherosclerosis by 73%.

Conclusions—These results suggest that SDG reduced hypercholesterolemic atherosclerosis and that this effect was associated with a decrease in serum cholesterol, LDL-C, and lipid peroxidation product and an increase in HDL-C and antioxidant reserve.


Key Words: atherosclerosis • hypercholesterolemia • flaxseed • chemiluminescence • antioxidants




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
P. R. Augusti, G. M. M. Conterato, S. Somacal, R. Sobieski, A. Quatrin, L. Maurer, M. P. Rocha, I. T. Denardin, and T. Emanuelli
Astaxanthin Reduces Oxidative Stress, but not Aortic Damage in Atherosclerotic Rabbits
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 314 - 322.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Prasad
Vitamin E Does Not Regress Hypercholesterolemic Atherosclerosis
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 231 - 241.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Pan, D. Yu, W. Demark-Wahnefried, O. H Franco, and X. Lin
Meta-analysis of the effects of flaxseed interventions on blood lipids
Am. J. Clinical Nutrition, August 1, 2009; 90(2): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Prasad
Flax Lignan Complex Slows Down the Progression of Atherosclerosis in Hyperlipidemic Rabbits
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2009; 14(1): 38 - 48.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. A. Austria, M. N. Richard, M. N. Chahine, A. L. Edel, L. J. Malcolmson, C. M.C. Dupasquier, and G. N. Pierce
Bioavailability of Alpha-Linolenic Acid in Subjects after Ingestion of Three Different Forms of Flaxseed
J. Am. Coll. Nutr., April 1, 2008; 27(2): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Prasad
A Study on Regression of Hypercholesterolemic Atherosclerosis in Rabbits by Flax Lignan Complex
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 304 - 313.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. M. C. Dupasquier, E. Dibrov, A. L. Kneesh, P. K. M. Cheung, K. G. Y. Lee, H. K. Alexander, B. K. Yeganeh, M. H. Moghadasian, and G. N. Pierce
Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2394 - H2402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. M. C. Dupasquier, A.-M. Weber, B. P. Ander, P. P. Rampersad, S. Steigerwald, J. T. Wigle, R. W. Mitchell, E. A. Kroeger, J. S. C. Gilchrist, M. M. Moghadasian, et al.
Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2987 - H2996.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. M.G.A. El-Ghar, M. Qureshi, A. Shoker, and K. Prasad
Oxidative stress in renal transplant patients who develop cardiovascular disease.
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 203 - 210.
[Abstract] [PDF]


Home page
J. Nutr.Home page
J. Hallund, I. Tetens, S. Bugel, T. Tholstrup, M. Ferrari, T. Teerlink, A. Kjaer, and N. Wiinberg
Daily Consumption for Six Weeks of a Lignan Complex Isolated from Flaxseed Does Not Affect Endothelial Function in Healthy Postmenopausal Women
J. Nutr., September 1, 2006; 136(9): 2314 - 2318.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Hallund, G. Ravn-Haren, S. Bugel, T. Tholstrup, and I. Tetens
A Lignan Complex Isolated from Flaxseed Does Not Affect Plasma Lipid Concentrations or Antioxidant Capacity in Healthy Postmenopausal Women
J. Nutr., January 1, 2006; 136(1): 112 - 116.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. Clavel, G. Henderson, C.-A. Alpert, C. Philippe, L. Rigottier-Gois, J. Dore, and M. Blaut
Intestinal Bacterial Communities That Produce Active Estrogen-Like Compounds Enterodiol and Enterolactone in Humans
Appl. Envir. Microbiol., October 1, 2005; 71(10): 6077 - 6085.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. M. Lane and M. R. Farlow
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
J. Lipid Res., May 1, 2005; 46(5): 949 - 968.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Stuglin and K. Prasad
Effect of Flaxseed Consumption on Blood Pressure, Serum Lipids, Hemopoietic System and Liver and Kidney Enzymes in Healthy Humans
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 23 - 27.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Prasad
C-Reactive Protein Increases Oxygen Radical Generation by Neutrophils
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 203 - 209.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. Lee and K. Prasad
Effects of Flaxseed Oil on Serum Lipids and Atherosclerosis in Hypercholesterolemic Rabbits
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 227 - 235.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. J. Bhathena, A. A. Ali, C. Haudenschild, P. Latham, T. Ranich, A. I. Mohamed, C. T. Hansen, and M. T. Velasquez
Dietary Flaxseed Meal is More Protective Than Soy Protein Concentrate Against Hypertriglyceridemia and Steatosis of the Liver in an Animal Model of Obesity
J. Am. Coll. Nutr., April 1, 2003; 22(2): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. Prasad and P. Lee
Suppression of Oxidative Stress as a Mechanism of Reduction of Hypercholesterolemic Atherosclerosis by Aspirin
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1): 61 - 69.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. J Bhathena and M. T Velasquez
Beneficial role of dietary phytoestrogens in obesity and diabetes
Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1191 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. S. Anthony
Phytoestrogens and Cardiovascular Disease: Where's the Meat?
Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1245 - 1247.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. A. Lucas, R. D. Wild, L. J. Hammond, D. A. Khalil, S. Juma, B. P. Daggy, B. J. Stoecker, and B. H. Arjmandi
Flaxseed Improves Lipid Profile without Altering Biomarkers of Bone Metabolism in Postmenopausal Women
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1527 - 1532.
[Abstract] [Full Text] [PDF]